BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1946543)

  • 61. A 'defence' hypothesis of the cancer cell.
    Lo JS; Kellen JA
    Biochem Exp Biol; 1978; 14(2):185-6. PubMed ID: 753376
    [No Abstract]   [Full Text] [Related]  

  • 62. Comments on incorporating mechanistic data into quantitative risk assessment.
    Frederick CB; Wilson AG
    Risk Anal; 1991 Dec; 11(4):581-2. PubMed ID: 1780499
    [No Abstract]   [Full Text] [Related]  

  • 63. Risk assessment of non-genotoxic carcinogens.
    Moolgavkar SH; Luebeck EG
    Toxicol Lett; 1992 Dec; 64-65 Spec No():631-6. PubMed ID: 1471217
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of cell proliferation in multistage carcinogenesis.
    Butterworth BE; Goldsworthy TL
    Proc Soc Exp Biol Med; 1991 Nov; 198(2):683-7. PubMed ID: 1924404
    [No Abstract]   [Full Text] [Related]  

  • 65. Toxicity, cell proliferation, and carcinogenesis.
    Weinstein IB
    Mol Carcinog; 1992; 5(1):2-3. PubMed ID: 1543538
    [No Abstract]   [Full Text] [Related]  

  • 66. Cell proliferation.
    Berry RJ
    Cell Tissue Kinet; 1977 Jan; 10(1):1-2. PubMed ID: 851988
    [No Abstract]   [Full Text] [Related]  

  • 67. Clonal adaptation during carcinogenesis.
    Farber E
    Biochem Pharmacol; 1990 Jun; 39(12):1837-46. PubMed ID: 2191651
    [No Abstract]   [Full Text] [Related]  

  • 68. Cell proliferation and changes in the large granule fraction during hepatic carcinogenesis.
    LAIRD AK
    Proc Soc Exp Biol Med; 1951 Jul; 77(3):434-7. PubMed ID: 14864616
    [No Abstract]   [Full Text] [Related]  

  • 69. Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
    Pitot HC; Dragan YP; Neveu MJ; Rizvi TA; Hully JR; Campbell HA
    Prog Clin Biol Res; 1991; 369():517-32. PubMed ID: 1946543
    [No Abstract]   [Full Text] [Related]  

  • 70. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
    [No Abstract]   [Full Text] [Related]  

  • 71. Chemically induced cell proliferation and carcinogenesis: differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat.
    Columbano A; Ledda-Columbano GM; Coni P; Pichiri-Coni G; Curto M; Pani P
    Prog Clin Biol Res; 1991; 369():217-25. PubMed ID: 1946520
    [No Abstract]   [Full Text] [Related]  

  • 72. Chemically induced cell proliferation in liver carcinogenesis.
    Popp JA; Marsman DS
    Prog Clin Biol Res; 1991; 369():389-95. PubMed ID: 1946534
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mitogenesis and programmed cell death as determinants of carcinogenicity of nongenotoxic compounds.
    Schulte-Hermann R; Bursch W; Parzefall W
    Prog Clin Biol Res; 1991; 369():237-44. PubMed ID: 1946522
    [No Abstract]   [Full Text] [Related]  

  • 74. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.
    Melnick RL; Huff J
    Toxicol Ind Health; 1993; 9(3):415-38. PubMed ID: 8367884
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.